Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M573Revenue $M136Net Margin (%)24.0Altman Z-Score8.9
Enterprise Value $M465EPS $0.7Operating Margin %36.8Piotroski F-Score7
P/E(ttm)16.3Beneish M-Score-3.2Pre-tax Margin (%)38.4Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %--Quick Ratio4.8Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %--Current Ratio4.8Lower Leverage y-yY
Price/Free Cash Flow11.9y-y EBITDA Growth Rate %231ROA % (ttm)21.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)34.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.3ROIC % (ttm)124Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SCMPJoel Greenblatt 2015-09-30 Reduce-0.03%$16.34 - $28.96
($22.93)
$ 11.53-50%Reduce -53.28%156,205
SCMPJoel Greenblatt 2015-06-30 Add0.03%$14.5 - $21.75
($17.31)
$ 11.53-33%Add 222.92%334,346
SCMPJoel Greenblatt 2015-03-31 Buy 0.01%$13.12 - $18.56
($15.5)
$ 11.53-26%New holding103,538
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SCMP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Smith Andrew PCFO 2015-11-16Buy1,605$17.03-32.3view
Getman Daniel PDirector 2015-08-28Sell30,000$28.14-59.03view
Knapp Thomas JFormer Officer 2015-07-20Sell64,528$23.43-50.79view
Kuno Sachiko10% Owner 2015-03-31Sell1,600,000$14-17.64view
S&R Technology Holdings, LLC10% Owner 2015-03-31Sell1,186,113$14-17.64view
Ueno Ryuji10% Owner 2015-03-31Sell1,600,000$14-17.64view
Ashton WilliamDirector 2015-03-12Sell129,766$17.42-33.81view
Celeste Anthony C.Director 2015-03-11Sell65,966$17.34-33.51view
Claiborne Cary JFormer Chief Financial Officer 2014-12-16Sell50,000$12.91-10.69view
S&R Technology Holdings, LLC10% Owner 2014-08-07Sell181,727$6.2883.6view

Quarterly/Annual Reports about SCMP:

News about SCMP:

Articles On GuruFocus.com
NeoPhotonics Delivers Sustained Profitability; Gevo Continues Biofuel Deal Momentum May 08 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 07 2009 

More From Other Websites
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 Leerink Global Healthcare... Feb 04 2016
Mirna Therapeutics Appoints Peter Greenleaf to Its Board of Directors Feb 01 2016
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jan 14 2016
Sucampo acquires exclusive option for cancer drug in deal worth up to $190 million Jan 11 2016
Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer Prevention... Jan 11 2016
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 11 2016
Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer Prevention... Jan 11 2016
Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno... Jan 07 2016
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition Jan 07 2016
Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno... Jan 07 2016
Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 1,... Jan 01 2016
Sucampo Shifts Into Growth With Hard-Charging CEO Dec 24 2015
Sucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : December 21,... Dec 21 2015
5 Stocks Ready for Breakouts Dec 18 2015
Sucampo Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 16 2015
Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors Dec 15 2015
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Dec 15 2015
Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors Dec 15 2015
SUCAMPO PHARMACEUTICALS, INC. Financials Dec 08 2015
Sucampo Completes Acquisition of R-Tech Ueno Dec 07 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK